Skip to content

febrile Seizure Treatment Assessment of Diazepam Therapy

febrile Seizure Treatment Assessment of Diazepam Therapy - fSTATDT study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019613
Enrollment
200
Registered
2015-11-04
Start date
2015-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile seuzure simplex

Interventions

Diazepam treatment apply: The examiner confirms that there are no neurological findings then apply 0.3mg/kg of Diazepam. The same dose of Diazepam will be applied after 8 hours. Diazepam treatment is

Sponsors

Juntendo University Nerima Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patients of febrile seizure simplex without previous seizure history

Exclusion criteria

Exclusion criteria: Informed consent was not meet

Design outcomes

Primary

MeasureTime frame
The effectiveness of diazepam treatment evaluated by inquiry post card. The examiner gives the card. The patient observes consious level, seizure and body temperature for 7 days. They will return the card after 8 days to reserach organization.

Countries

Japan

Contacts

Public ContactNoboru Yoshida

Juntendo University Nerima Hospital Pediatrics Division

noyoshi@juntendo.ac.jp03-5923-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026